Sleep and immunotherapy response in stomach cancer
Part of Cancer, Digestive system, Immune system & allergy clinical trials.
This trial looks at how sleep patterns affect how well immunotherapy works before surgery for people with stomach or gastroesophageal junction cancer. Researchers want to understand if sleep quality is linked to better treatment response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a confirmed diagnosis of stomach cancer or cancer where the stomach meets the esophagus (gastroesophageal junction) that is advanced but can still be surgically removed.
- You are scheduled to have treatment (like immunotherapy) before surgery, followed by surgery.
- You have not had any prior treatment for this cancer (like chemo, immunotherapy, or radiation).
- You are generally in good health (able to do your daily activities) and do not have severe memory or mental health issues.
- You have not changed any medications for depression, anxiety, or sleep in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination approach to improve poor sleep in people with advanced cancer. If you qualify, you would answer sleep and symptom questions and may do a structured therapy (CBT) plus follow-up visits.
This trial collects tissue samples to study why some stomach cancers become resistant to treatment. It aims to better understand how tumors and their surroundings interact, which could help doctors choose the right therapy for each patient.
This trial tests whether adding an immunotherapy drug (QL1706) to a standard chemotherapy regimen, given before surgery, can help shrink stomach or gastroesophageal junction cancer. The goal is to improve the chance of successful surgery and long-term outcomes.
This study looks at how sleep disturbances affect how well lung cancer treatments work. It may help doctors understand if improving sleep can lead to better treatment results.
This study looks at how sleep problems affect immunotherapy for people with lung cancer. If you have non-small-cell lung cancer and are about to start immunotherapy, you may be able to join.
This study looks at how sleep changes during breast cancer treatment and how those changes relate to certain markers in the body. It aims to help improve sleep and overall health for people with hormone receptor positive breast cancer.
Hear when a new Gastric Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.